Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Topical mesalazine as a cause of Stevens-Johnson syndrome.
Núñez Ortiz A, Trigo Salado C, de la Cruz Ramírez MD, Herrera Justiniano JM, Leo Carnerero E. Núñez Ortiz A, et al. Rev Esp Enferm Dig. 2018 Nov;110(11):736-738. doi: 10.17235/reed.2018.5429/2017. Rev Esp Enferm Dig. 2018. PMID: 29931986 Free article.
Pancreatobiliary maljunction: association with gallbladder cancer.
Garzón Benavides M, Núñez Ortiz A, López Ruiz T, Cepeda Franco C, Gómez Izquierdo L. Garzón Benavides M, et al. Among authors: nunez ortiz a. Rev Esp Enferm Dig. 2019 Jul;111(7):568-570. doi: 10.17235/reed.2019.6127/2018. Rev Esp Enferm Dig. 2019. PMID: 31215211 Free article.
Megacolon in inflammatory bowel disease: response to infliximab.
Núñez Ortiz A, Trigo Salado C, de la Cruz Ramírez MD, Márquez Galán JL, Herrera Justiniano JM, Leo Carnerero E. Núñez Ortiz A, et al. Rev Esp Enferm Dig. 2020 Feb;112(2):90-93. doi: 10.17235/reed.2020.6394/2019. Rev Esp Enferm Dig. 2020. PMID: 31960698 Free article.
Perianal Crohn's disease: clinical implications, prognosis and use of resources.
Martínez Sánchez ER, Solá Fernández A, Pérez Palacios D, Núñez Ortiz A, de la Cruz Ramírez MD, Leo Carnerero E, Trigo Salado C, Herrera Justiniano JM. Martínez Sánchez ER, et al. Among authors: nunez ortiz a. Rev Esp Enferm Dig. 2022 May;114(5):254-258. doi: 10.17235/reed.2021.7918/2021. Rev Esp Enferm Dig. 2022. PMID: 34425681 Free article.
Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia.
Hernández Martínez A, Navajas Hernández P, Martín Rodríguez MDM, Lázaro Sáez M, Olmedo Martín R, Núñez Ortiz A, Argüelles Arias F, Fernández Cano MC, Gallardo Sánchez F, Marín Pedrosa S, González García J, Vázquez Morón JM. Hernández Martínez A, et al. Among authors: nunez ortiz a. Rev Esp Enferm Dig. 2022 Sep;114(9):516-521. doi: 10.17235/reed.2022.8380/2021. Rev Esp Enferm Dig. 2022. PMID: 35000397 Free article.
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Casanova MJ, Nantes Ó, Varela P, Vela-González M, Rivero M, Sierra-Gabarda O, Riestra S, Barreiro-de Acosta M, Martín-Rodríguez MDM, Gargallo-Puyuelo CJ, Reygosa C, Muñoz R, de la Filia-Molina IG, Núñez-Ortiz A, Kolle L, Calafat M, Huguet JM, Iglesias-Flores E, Martínez-Pérez TJ, Bosch O, Duque-Alcorta JM, Frago-Larramona S, Van Domselaar M, González-Cosano VM, Bujanda L, Rubio S, Mancebo A, Castro B, García-López S, de Francisco R, Nieto-García L, Laredo V, Gutiérrez-Casbas A, Mesonero F, Leo-Carnerero E, Cañete F, Ruiz L, Gros B, Del Moral-Martínez M, Rodríguez C, Chaparro M, Gisbert JP. Casanova MJ, et al. Among authors: nunez ortiz a. Aliment Pharmacol Ther. 2023 Jul;58(1):60-70. doi: 10.1111/apt.17525. Epub 2023 Apr 23. Aliment Pharmacol Ther. 2023. PMID: 37089065
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Casanova MJ, Chaparro M, Nantes Ó, Benítez JM, Rojas-Feria M, Castro-Poceiro J, Huguet JM, Martín-Cardona A, Aicart-Ramos M, Tosca J, Martín-Rodríguez MDM, González-Muñoza C, Mañosa M, Leo-Carnerero E, Lamuela-Calvo LJ, Pérez-Martínez I, Bujanda L, Hinojosa J, Pajares R, Argüelles-Arias F, Pérez-Calle JL, Rodríguez-González GE, Guardiola J, Barreiro-de Acosta M, Gisbert JP; EVODIS Study Group*. Casanova MJ, et al. Aliment Pharmacol Ther. 2021 Jun;53(12):1277-1288. doi: 10.1111/apt.16361. Epub 2021 May 7. Aliment Pharmacol Ther. 2021. PMID: 33962482
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Botella B, Sapiña A, Cruz N, Forcelledo JLF, Bouhmidi A, Castaño-Milla C, Opio V, Nicolás I, Kutz M, Abraldes Bechiarelli A, Gordillo J, Ber Y, Torres Domínguez Y, Novella… See abstract for full author list ➔ Chaparro M, et al. Among authors: nunez ortiz a. J Clin Med. 2021 Jun 29;10(13):2885. doi: 10.3390/jcm10132885. J Clin Med. 2021. PMID: 34209680 Free PMC article.
15 results